Chapel Hill, NC, United States of America

Elaine Gay

This inventor holds 1 USPTO granted patent. Top assignee: Research Triangle Institute. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elaine Gay. Retrieved from https://idiyas.com/inventor/elaine-gay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elaine Gay and Her Patent on RXFP3 Antagonists.

Introduction

Elaine Gay is an inventor associated with Chapel Hill, North Carolina, and Research Triangle Institute. Her work includes a patent describing small-molecule antagonists for the relaxin-3/RXFP3 system.

Latest Patents

The patent, “Small Molecule Antagonists for the Relaxin-3/RXFP3 System,” describes non-peptide compounds that inhibit activity at the relaxin family peptide 3 receptor, RXFP3. The compounds may include a pyrrolidone or piperidone substituted with an aryl amide. The patent also describes methods for preparing and using these antagonists, including potential applications involving obesity, alcoholism, substance abuse, and addiction-related conditions. Elaine Gay is associated with 1 patent.

Career Highlights

Gay’s patent reflects research into compounds that target RXFP3 and their possible therapeutic uses. She is associated with Research Triangle Institute.

Collaborations

Chunyang Jin is identified as a coworker associated with Gay.

Conclusion

Elaine Gay’s patent documents an approach to developing small-molecule RXFP3 antagonists and exploring their potential use in treating several health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…